Will Viking Therapeutics be acquired before 2027?

Market suggests a lower likelihood of Viking Therapeutics being acquired before 2027.

The prediction market indicates a 41.5% chance of Viking Therapeutics being acquired before 2027, with a higher probability of 58.5% for no acquisition. The Pulse AI probability aligns closely, suggesting a moderate consensus on the likelihood of acquisition. The market appears fairly priced with a confidence level of 65 out of 100.

• 1 Current market sentiment leans towards no acquisition.
• 2 The probabilities from market and AI are closely aligned.
• 3 A confidence score of 65 indicates moderate certainty.
• 4 Time to expiry is substantial, allowing for potential developments.
• 5 Market appears fairly priced with an edge of 3.

This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire the listed company by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.

An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.

The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.